Study Implicates Two Genetic Variants in Bicuspid Aortic Valve Development

Researchers report a key protein is affected during heart valve formation, in the first genomewide study of bicuspid aortic valve.

5:00 AM

Author | Haley Otman

Researchers are working to determine why the aortic valve doesn't form correctly in patients with the most common congenital heart defect: bicuspid aortic valve.

MORE FROM THE LAB: Subscribe to our weekly newsletter

In a new Nature Communications study, the Michigan Medicine-led group found two genetic variants associated with the condition.

Bicuspid aortic valve is moderately heritable, yet experts are still figuring out which part of our DNA code explains why some BAV patients inherit the disease.

"We've completed the first successful genomewide study of bicuspid aortic valve, by studying subjects at U-M's Frankel Cardiovascular Center," says first author Bo Yang, M.D., Ph.D., a Michigan Medicine cardiac surgeon. "We are using state-of-the-art technology of induced stem cell and gene editing to dissect the genomic region we found to be associated with BAV. It's a great collaboration that will accelerate our scientific understanding of this disease."

BAV patients have aortic valves with only two leaflets, rather than three, limiting the valve's function as the heart pumps oxygen-rich blood toward the aorta to enrich the body. The condition is associated with various complications, including a narrowed valve (aortic stenosis), a leaky valve (aortic insufficiency or regurgitation), an infection of the valve or an aortic aneurysm.

This finding gives us a great head start toward understanding the mechanism of how a genetic change outside the protein-coding part of the genome can lead to disease.
Cristen Willer, Ph.D.

'A great head start'

The researchers performed genomewide association scans of 466 BAV cases from the Frankel Cardiovascular Center and 4,660 controls from the Michigan Genomics Initiative, with replication on 1,326 cases and 8,103 controls from collaborators at other leading institutions. They also reprogrammed the matured white blood cells to change them back into immortal cells (stem cells) and changed the genetic code of those cells to study the function of the variants they identified through the genomewide association study.

SEE ALSO: Jimmy Kimmel Sheds Light on How Health Policy Affects Children with Congenital Heart Disease

The team reports two genetic variants, both affecting a key cardiac transcription factor called GATA4, reached or nearly reached genomewide significance in BAV. GATA4 is a protein important to cardiovascular development in the womb, and GATA4 mutations have been associated with other cardiovascular defects.

"One of the regions we identify actually changes the protein coded by the gene, and the other likely changes expression levels of GATA4 during valve formation," says senior author Cristen Willer, Ph.D., professor of internal medicine, human genetics and computational medicine and bioinformatics. "Because most genetic variants associated with human disease are in the 99 percent of the genome that doesn't code for proteins, this finding gives us a great head start toward understanding the mechanism of how a genetic change outside the protein-coding part of the genome can lead to disease."

Specifically, the authors point to a disruption during the endothelial-mesenchymal transition, which is a critical step in the development of the aortic valve. Willer and Yang say this study, with support from the Frankel CVC and the Bob and Ann Aikens Aortic Program, adds new knowledge about the mechanism of BAV formation. They plan to continue to study the biological effect of both variants associated BAV in cells and animal models.

Collaborators from a variety of institutions provided replication of the result, including Harvard Medical School, the University of Texas, the Montreal Heart Institute, the Karolinska Institute and Icahn School of Medicine at Mount Sinai.


More Articles About: Lab Report Congenital Heart Disease Valve Disease Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Microscopic image of bone marrow with pink and white hues
Health Lab
Novel risk score for cardiovascular complications after bone marrow transplant
More bone marrow transplants, also known as hematopoietic stem cell transplantation, are being offered to older patients, a population at greater risk of cardiovascular disease.
dna strand
Health Lab
Female genetic markers may have greater effect on hypertension, certain cardiovascular diseases
Female genetic markers may have greater effect on hypertension, certain cardiovascular diseases
Adult performs CPR on a young athlete, illustration with red and blue figures
Health Lab
Sudden cardiac arrest in young athletes: 5 things parents should know
Sudden cardiac arrest in young athletes: 5 things parents should know
Mom and daughter pose in two separate photos about 30 years apart. Daughter had a congenital heart issue, now is an adult.
Health Lab
Mother daughter duo reflect on nearly three decade heart journey
Mother, daughter reflect on congenital heart treatment and decades long treatment
Provider takes a pulse oximetry reading from a patient's finger
Health Lab
Inaccurate pulse oximeter readings could limit transplants, heart pumps for Black patients with heart failure
Racially biased readings of oxygen levels in the blood using pulse oximeters may further limit opportunities for Black patients with heart failure to receive potentially lifesaving treatments, such as heart pumps and transplants
Illustration of a magenta heart with white plaque on a golden background.
Health Lab
What is heart disease?
Tanuka Piech, M.D., a cardiologist at the University of Michigan Health Frankel Cardiovascular Center, answers questions about heart disease, why we should care and what we can do to help prevent it.